The Asia-Pacific flow cytometry market is witnessing rapid growth, fueled by a surging demand for advanced diagnostics and research solutions. Key drivers propelling this market expansion include an increasing prevalence of chronic diseases, growing allocation in healthcare infrastructure, and a surge in research activities in the biotechnology and